These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 11289159)

  • 1. Soluble decoy receptor 3 is expressed by malignant gliomas and suppresses CD95 ligand-induced apoptosis and chemotaxis.
    Roth W; Isenmann S; Nakamura M; Platten M; Wick W; Kleihues P; Bähr M; Ohgaki H; Ashkenazi A; Weller M
    Cancer Res; 2001 Mar; 61(6):2759-65. PubMed ID: 11289159
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sensitization of cells to TRAIL-induced apoptosis by decoy receptor 3.
    Wu YY; Chang YC; Hsu TL; Hsieh SL; Lai MZ
    J Biol Chem; 2004 Oct; 279(42):44211-8. PubMed ID: 15475369
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum concentration of soluble decoy receptor 3 in glioma patients before and after surgery.
    Hwang SL; Lin CL; Cheng CY; Lin FA; Lieu AS; Howng SL; Lee KS
    Kaohsiung J Med Sci; 2004 Mar; 20(3):124-7. PubMed ID: 15124896
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Endogenous decoy receptor 3 blocks the growth inhibition signals mediated by Fas ligand in human pancreatic adenocarcinoma.
    Tsuji S; Hosotani R; Yonehara S; Masui T; Tulachan SS; Nakajima S; Kobayashi H; Koizumi M; Toyoda E; Ito D; Kami K; Mori T; Fujimoto K; Doi R; Imamura M
    Int J Cancer; 2003 Aug; 106(1):17-25. PubMed ID: 12794752
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CD95 ligand: lethal weapon against malignant glioma?
    Weller M; Kleihues P; Dichgans J; Ohgaki H
    Brain Pathol; 1998 Apr; 8(2):285-93. PubMed ID: 9546287
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Attenuation of Th1 response in decoy receptor 3 transgenic mice.
    Hsu TL; Wu YY; Chang YC; Yang CY; Lai MZ; Su WB; Hsieh SL
    J Immunol; 2005 Oct; 175(8):5135-45. PubMed ID: 16210617
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Frequent gene amplification and overexpression of decoy receptor 3 in glioblastoma.
    Arakawa Y; Tachibana O; Hasegawa M; Miyamori T; Yamashita J; Hayashi Y
    Acta Neuropathol; 2005 Mar; 109(3):294-8. PubMed ID: 15627206
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CCNU-dependent potentiation of TRAIL/Apo2L-induced apoptosis in human glioma cells is p53-independent but may involve enhanced cytochrome c release.
    Röhn TA; Wagenknecht B; Roth W; Naumann U; Gulbins E; Krammer PH; Walczak H; Weller M
    Oncogene; 2001 Jul; 20(31):4128-37. PubMed ID: 11464279
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The prognostic significance of overexpression of the decoy receptor for Fas ligand (DcR3) in patients with gastric carcinomas.
    Takahama Y; Yamada Y; Emoto K; Fujimoto H; Takayama T; Ueno M; Uchida H; Hirao S; Mizuno T; Nakajima Y
    Gastric Cancer; 2002; 5(2):61-8. PubMed ID: 12111580
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Blockade of the Fas/FasL system improves pneumococcal clearance from the lungs without preventing dissemination of bacteria to the spleen.
    Matute-Bello G; Liles WC; Frevert CW; Dhanireddy S; Ballman K; Wong V; Green RR; Song HY; Witcher DR; Jakubowski JA; Martin TR
    J Infect Dis; 2005 Feb; 191(4):596-606. PubMed ID: 15655784
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Decoy receptor 3 (DcR3) is proteolytically processed to a metabolic fragment having differential activities against Fas ligand and LIGHT.
    Wroblewski VJ; Witcher DR; Becker GW; Davis KA; Dou S; Micanovic R; Newton CM; Noblitt TW; Richardson JM; Song HY; Hale JE
    Biochem Pharmacol; 2003 Feb; 65(4):657-67. PubMed ID: 12566095
    [TBL] [Abstract][Full Text] [Related]  

  • 12. APRIL, a new member of the tumor necrosis factor family, modulates death ligand-induced apoptosis.
    Roth W; Wagenknecht B; Klumpp A; Naumann U; Hahne M; Tschopp J; Weller M
    Cell Death Differ; 2001 Apr; 8(4):403-10. PubMed ID: 11550092
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genomic amplification of a decoy receptor for Fas ligand in lung and colon cancer.
    Pitti RM; Marsters SA; Lawrence DA; Roy M; Kischkel FC; Dowd P; Huang A; Donahue CJ; Sherwood SW; Baldwin DT; Godowski PJ; Wood WI; Gurney AL; Hillan KJ; Cohen RL; Goddard AD; Botstein D; Ashkenazi A
    Nature; 1998 Dec; 396(6712):699-703. PubMed ID: 9872321
    [TBL] [Abstract][Full Text] [Related]  

  • 14. NF-kappaB-independent actions of sulfasalazine dissociate the CD95L- and Apo2L/TRAIL-dependent death signaling pathways in human malignant glioma cells.
    Hermisson M; Weller M
    Cell Death Differ; 2003 Sep; 10(9):1078-89. PubMed ID: 12934082
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Irradiation induced clonogenic cell death of human malignant glioma cells does not require CD95/CD95L interactions.
    Streffer JR; Schuster M; Pohl U; Belka C; Dichgans J; Bamberg M; Weller M
    Anticancer Res; 1999; 19(6B):5265-9. PubMed ID: 10697547
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Overexpression of decoy receptor 3 in hepatocellular carcinoma and its association with resistance to Fas ligand-mediated apoptosis.
    Shen HW; Gao SL; Wu YL; Peng SY
    World J Gastroenterol; 2005 Oct; 11(38):5926-30. PubMed ID: 16273601
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Death decoy receptor TR6/DcR3 inhibits T cell chemotaxis in vitro and in vivo.
    Shi G; Wu Y; Zhang J; Wu J
    J Immunol; 2003 Oct; 171(7):3407-14. PubMed ID: 14500635
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Direct stimulation of apoptotic signaling by soluble Apo2l/tumor necrosis factor-related apoptosis-inducing ligand leads to selective killing of glioma cells.
    Pollack IF; Erff M; Ashkenazi A
    Clin Cancer Res; 2001 May; 7(5):1362-9. PubMed ID: 11350907
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hypoxia sensitizes human malignant glioma cells towards CD95L-induced cell death.
    Steinbach JP; Wolburg H; Klumpp A; Weller M
    J Neurochem; 2005 Mar; 92(6):1340-9. PubMed ID: 15748153
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Functional characterisation of decoy receptor 3 in Crohn's disease.
    Funke B; Autschbach F; Kim S; Lasitschka F; Strauch U; Rogler G; Gdynia G; Li L; Gretz N; Macher-Goeppinger S; Sido B; Schirmacher P; Meuer SC; Roth W
    Gut; 2009 Apr; 58(4):483-91. PubMed ID: 19039087
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.